輸入代號或公司名稱後按 Enter
AORT

ARTIVION, INC.

-0.90 (-3.60%)前一交易日收盤 2026-09-17
美股 · NYSE · 醫療器材 · 外科與醫療器材SIC 3841
24.12USD92.0K成交股數1.2B市值本益比(近四季)2.5股價營收比+11.3%營收年增(近四季)2026-11-05下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營收126M+11%116M+18%116M+21%113M+16%113M+16%99.0M+6%95.8M+9%98.0M+10%97.4M93.7M87.9M89.3M
營業成本45.2M40.9M42.8M39.0M39.9M35.4M34.8M34.7M34.5M32.6M31.6M31.2M
毛利80.5M+10%75.4M+19%73.1M+20%74.4M+17%73.1M+16%63.6M+4%61.0M+8%63.3M+9%62.9M61.1M56.3M58.1M
毛利率64.0%64.9%63.1%65.6%64.7%64.2%63.7%64.6%64.6%65.2%64.0%65.1%
研發費用9.1M8.8M9.1M8.1M7.1M6.7M6.6M7.5M6.9M7.6M6.4M7.4M
銷售管理費用79.8M60.8M56.8M57.3M57.7M54.7M50.0M49.3M30.7M50.3M51.1M57.2M
營業利益−8.4M-200%5.8M+170%10.7M+143%12.5M+93%8.4M-67%2.1M-32%4.4M-453%6.5M-15%25.3M3.2M−1.2M7.7M
營業利益率-6.7%5.0%9.2%11.1%7.4%2.2%4.6%6.6%26.0%3.4%-1.4%8.6%
稅後淨利−13.5M-1104%1.4M-381%2.4M-206%6.5M-407%1.3M-82%−505K-87%−2.3M-77%−2.1M-37%7.5M−4.0M−9.8M−3.4M
淨利率-10.7%1.2%2.1%5.7%1.2%-0.5%-2.4%-2.2%7.7%-4.2%-11.2%-3.8%
稀釋 EPS-0.28-1033%0.03-400%0.06-220%0.13-360%0.03-83%-0.01-90%-0.05-79%-0.05-38%0.18-0.10-0.24-0.08
稀釋股數48.5M49.7M47.2M48.8M45.4M42.2M41.8M41.7M47.9M40.7M40.9M40.8M

資產負債表 期末餘額

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
現金與約當現金77.3M55.8M64.9M73.4M53.5M37.7M56.2M55.0M51.1M58.9M53.5M48.8M
應收帳款97.9M91.9M89.8M88.1M91.4M87.8M75.7M73.9M74.3M71.8M64.3M64.8M
存貨103M98.0M92.4M90.5M86.7M81.9M84.1M80.8M81.7M82.0M78.8M78.5M
總資產1.1B883M885M858M838M791M803M790M784M792M775M778M
有息負債363M215M215M215M216M315M214M313M313M306M306M306M
總負債626M433M437M419M418M497M498M494M489M511M503M495M
股東權益446M450M448M439M420M294M305M295M295M282M272M283M
負債比58.4%49.0%49.3%48.9%49.9%62.8%62.1%62.6%62.4%64.4%64.9%63.7%
淨現金(現金 − 有息負債)−286M−160M−150M−141M−162M−277M−158M−258M−262M−247M−252M−257M

現金流量表 單季

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營業現金流1.2M-107%−17.0M−5.5M
資本支出8.0M3.6M3.6M
自由現金流−6.8M-67%−20.6M−9.1M
折舊攤銷6.3M5.4M5.9M
買回庫藏股
現金股利
自由現金流率-5.9%-20.8%-9.3%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

業務分部2025 年度 · 315M
Europe The Middle East And Africa Segments151M48.0%+15.1%
Preservation Services95.5M30.3%-2.9%
亞太44.3M14.0%+18.9%
Latin America24.0M7.6%+9.6%
Medical Devices 小計346M109.8%+19.2%
North America 小計222M70.4%+12.0%
地區2025 年度 · 441M
美國以外227M51.5%+14.5%
美國214M48.5%+12.7%
產品/服務2025 年度 · 787M
Products346M43.9%+19.2%
Aortic Stent Grafts159M20.2%+29.5%
On X102M12.9%+21.1%
Preservation Services95.5M12.1%-2.9%
Surgical Sealants76.6M9.7%+3.7%
Other Products8.1M1.0%-12.5%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY2025441M+13.6%9.8M2.2%0.21839K
FY2024389M+9.8%−13.4M-3.4%-0.3211.0M
FY2023354M+12.8%−30.7M-8.7%-0.759.1M
FY2022314M+5.0%−19.2M-6.1%-0.48−15.9M
FY2021299M+18.0%−14.8M-5.0%-0.38−15.7M
FY2020253M-8.3%−16.7M-6.6%-0.445.0M
FY2019276M+5.1%1.7M0.6%0.057.8M
FY2018263M−2.8M-1.1%-0.084.1M